CVRx, Inc. financial data

Symbol
CVRX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, MN
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.18K % -16.5%
Quick Ratio 124 % +8.71%
Debt-to-equity 69.5 % +203%
Return On Equity -89.1 % -99.6%
Return On Assets -52.6 % -44.8%
Operating Margin -125 % +2.47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.3M shares +16.6%
Common Stock, Shares, Outstanding 24.2M shares +16.3%
Entity Public Float 190M USD +163%
Common Stock, Value, Issued 242K USD +16.3%
Weighted Average Number of Shares Outstanding, Basic 22.8M shares +9.53%
Weighted Average Number of Shares Outstanding, Diluted 22.8M shares +9.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 47.3M USD +34.4%
Cost of Revenue 7.48M USD +23.8%
Research and Development Expense 10.6M USD -15%
Operating Income (Loss) -58.9M USD -31.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -58.3M USD -37.4%
Income Tax Expense (Benefit) 165K USD +21.3%
Net Income (Loss) Attributable to Parent -58.5M USD -37.4%
Earnings Per Share, Basic -2.71 USD/shares -32.2%
Earnings Per Share, Diluted -1.15 USD/shares +43.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 100M USD +20.7%
Accounts Receivable, after Allowance for Credit Loss, Current 9.03M USD +41.8%
Inventory, Net 11.9M USD +9.23%
Assets, Current 124M USD +19.6%
Property, Plant and Equipment, Net 2.63M USD +52.7%
Operating Lease, Right-of-Use Asset 1.14M USD +8.13%
Other Assets, Noncurrent 26K USD 0%
Assets 128M USD +20%
Accounts Payable, Current 3.28M USD +189%
Employee-related Liabilities, Current 274K USD -2.14%
Accrued Liabilities, Current 7.67M USD +22.3%
Liabilities, Current 10.9M USD +47.8%
Operating Lease, Liability, Noncurrent 951K USD +3.82%
Other Liabilities, Noncurrent 1.38M USD +43.5%
Liabilities 62.5M USD +165%
Accumulated Other Comprehensive Income (Loss), Net of Tax -208K USD 0%
Retained Earnings (Accumulated Deficit) -527M USD -12.5%
Stockholders' Equity Attributable to Parent 65.2M USD -21.3%
Liabilities and Equity 128M USD +20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -6.31%
Net Cash Provided by (Used in) Financing Activities 1.36M USD -82%
Net Cash Provided by (Used in) Investing Activities -917K USD -282%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 24.2M shares +16.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.5M USD -258%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 100M USD +20.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 770K USD +310%
Deferred Tax Assets, Valuation Allowance 111M USD +8.56%
Deferred Tax Assets, Gross 111M USD +8.56%
Operating Lease, Liability 1.23M USD +12.9%
Depreciation 570K USD +9.41%
Payments to Acquire Property, Plant, and Equipment 917K USD +282%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -58.5M USD -37.4%
Lessee, Operating Lease, Liability, to be Paid 1.4M USD +13.4%
Property, Plant and Equipment, Gross 5.86M USD +33.7%
Operating Lease, Liability, Current 275K USD +61.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 362K USD +42%
Lessee, Operating Lease, Liability, to be Paid, Year One 350K USD +57%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 169K USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 374K USD +42.7%
Deferred Tax Assets, Operating Loss Carryforwards 89.2M USD +8.68%
Unrecognized Tax Benefits 2.22M USD +8.55%
Lessee, Operating Lease, Liability, to be Paid, Year Four 223K USD -17.4%
Operating Lease, Payments 100K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 18M USD +211%
Interest Expense 2.52M USD +522%